Inspiring stories and helpful discussions

Hear from real patients and experts, and see how this proven therapy has helped more than 250,000 people worldwide.

On-Demand Webinar

Firsthand experiences from a real doctor and patient

Watch a cardiologist and patient discuss living with mitral regurgitation, making treatment decisions, and the impact MitraClip™ Therapy has had on the patient's life.

On-demand webinar

Patient Testimonial

Real stories. Real results.

Hear directly from Scott, who is living with mitral regurgitation, received MitraClip Therapy, and has reclaimed his life since treatment.

Scott, MitraClip Therapy patient

PBS Special

A documentary on mitral regurgitation

Watch the PBS documentary from the Emmy award-winning series Medical Stories exploring the impact of mitral regurgitation and the lives changed by treatment.

Watch a PBS special on mitral regurgitation

Understanding Mitral Regurgitation

A closer look at a leaky valve

Learn how a leaky mitral valve affects the body and some of the treatments available to address it.

Understanding mitral regurgitation video

Is MitraClip Therapy right for me?

Use our quick questionnaire to see if you might be a candidate for MitraClip Therapy.

Start Questionnaire

Start an assessment

Ready to discuss with your doctor?

If your mitral regurgitation symptoms are interrupting your daily life, download this discussion guide to prepare for your next doctor’s appointment.

Download Discussion Guide

Important Safety Information

Important Safety Information

What is MitraClip™ Therapy approved for?

Available by prescription only.

MitraClip therapy is a minimally invasive procedure approved for treating patients with clinically significant mitral regurgitation due to either (a) a deteriorated mitral valve in patients who are deemed to be at prohibitive risk for surgery, or (b) mitral valve in patients who have heart failure and reduced pumping function who remain symptomatic despite maximally tolerated medications to treat their heart failure.

Patients should work with their doctor and a multidisciplinary heart team, which may include a heart surgeon and cardiologist with experience treating heart failure, to confirm their surgical risk and to ensure that they are on the optimal medications. The heart team will determine if transcatheter edge-to-edge valve repair is clinically appropriate, and if the patient meets the indications for the MitraClip procedure.

Who should not have the MitraClip Procedure?

Patients that have any of the following conditions may not be good candidates for the MitraClip Procedure: Patients with intolerance or allergy to procedural anticoagulation, untreatable hypersensitivity to implant components (nickel-titanium alloy, cobalt-chromium alloy), or active endocarditis or other active infection of the mitral valve.

What are the possible complications associated with the MitraClip Procedure?

As with any medical procedure, there is a possibility of complications. The most serious complications of the MitraClip procedure includes, but are not limited to: death, stroke (a condition in which decreased blood flow to the brain can result in brain damage and may cause severe disability), transient ischemic attack (stroke symptoms that last only a few minutes), major vascular complications (damage to a major blood vessel that may require emergency surgery or urgent cardiac surgery), life threatening bleeding event (a major bleeding event that requires a blood transfusion). For additional potential risks and complications, please consult with your physician or heart team.

Talk to your doctor to learn more about the risks associated with MitraClip Therapy and ask for the detailed Important Safety Information if you'd like to review the full list of complications.

Data on file at Abbott.

MAT-2600331 v1.0 | Item approved for U.S. use only